» Articles » PMID: 26865046

Circulating Memory T Follicular Helper Subsets, Tfh2 and Tfh17, Participate in the Pathogenesis of Guillain-Barré Syndrome

Overview
Journal Sci Rep
Specialty Science
Date 2016 Feb 12
PMID 26865046
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Circulating memory T follicular helper subsets, Tfh2 and Tfh17 are found to be aberrantly regulated in many autoimmune diseases. However, their roles in the pathogenesis of GBS are still unclear. This study examined the phenotype, distribution, clinical relevance and potential function of Tfh2 and Tfh17 in 36 GBS patients (including 24 AMAN and 12 AIDP patients). We found that the absolute counts of total memory Tfh cells were significantly increased in AMAN, while no significant difference in AIDP compared with HC. Furthermore, the levels of the three subsets of memory Tfh cells, Tfh1, Tfh2 and Tfh17, were differentially altered in AMAN. The absolute counts of Tfh1, Tfh2 and Tfh17 were all increased to a higher level in AMAN. The ratio of (Tfh2+Tfh17)/Tfh1 and the percentages of ICOS(+) cells in Tfh2 and Tfh17 cells were greater in AMAN when compared to AIDP and HC, and the former had a positive correlation with the severity of both AMAN and AIDP. Conversely, the percentages of PD1(+) cells in Tfh2 and Tfh17 cells were lower in AMAN than in HC. Therefore, circulating memory Tfh2 and Tfh17 cells might promote the autoantibody-related immune response and serve as useful markers to evaluate the progression of AMAN.

Citing Articles

New T-lymphocyte subpopulations and their characteristics: Challenges to the classical division of lymphocyte function.

Lewandowski F, Niedzwiedzka-Rystwej P Cent Eur J Immunol. 2024; 49(3):308-314.

PMID: 39720272 PMC: 11664807. DOI: 10.5114/ceji.2024.144071.


Insights into the clinical, immunologic, and genetic underpinnings of food allergy.

Frischmeyer-Guerrerio P, Young F, Aktas O, Haque T Immunol Rev. 2024; 326(1):162-172.

PMID: 39034662 PMC: 11436304. DOI: 10.1111/imr.13371.


Autoreactive T cells target peripheral nerves in Guillain-Barré syndrome.

Sukenikova L, Mallone A, Schreiner B, Ripellino P, Nilsson J, Stoffel M Nature. 2024; 626(7997):160-168.

PMID: 38233524 PMC: 10830418. DOI: 10.1038/s41586-023-06916-6.


Hyperbaric oxygen therapy improves recovery at acute motor axonal neuropathy case.

Untari N, Kusumastuti K, Suryokusumo G, Sudiana I J Neurosci Rural Pract. 2023; 14(1):145-148.

PMID: 36891088 PMC: 9944315. DOI: 10.25259/JNRP_9_2022.


Real-world data on the incidence and risk of Guillain-Barré syndrome following SARS-CoV-2 vaccination: a prospective surveillance study.

Ha J, Park S, Kang H, Kyung T, Kim N, Kim D Sci Rep. 2023; 13(1):3773.

PMID: 36882454 PMC: 9989583. DOI: 10.1038/s41598-023-30940-1.


References
1.
Uncini A, Kuwabara S . Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update. Clin Neurophysiol. 2012; 123(8):1487-95. DOI: 10.1016/j.clinph.2012.01.025. View

2.
Kleyweg R, van der Meche F, Meulstee J . Treatment of Guillain-Barré syndrome with high-dose gammaglobulin. Neurology. 1988; 38(10):1639-41. DOI: 10.1212/wnl.38.10.1639. View

3.
Abraham P, Quan S, Dukala D, Soliven B . CD19 as a therapeutic target in a spontaneous autoimmune polyneuropathy. Clin Exp Immunol. 2013; 175(2):181-91. PMC: 3892409. DOI: 10.1111/cei.12215. View

4.
Linterman M, Rigby R, Wong R, Yu D, Brink R, Cannons J . Follicular helper T cells are required for systemic autoimmunity. J Exp Med. 2009; 206(3):561-76. PMC: 2699132. DOI: 10.1084/jem.20081886. View

5.
Topalian S, Drake C, Pardoll D . Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity. Curr Opin Immunol. 2012; 24(2):207-12. PMC: 3319479. DOI: 10.1016/j.coi.2011.12.009. View